CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
79,314,318
Share change
-362,073
Total reported value
$1,027,918,770
Put/Call ratio
109%
Price per share
$12.96
Number of holders
143
Value change
-$10,435,700
Number of buys
71
Number of sells
55

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q3 2014

As of 30 Sep 2014, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,314,318 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, OPPENHEIMER FUNDS INC, VANGUARD GROUP INC, COLUMBIA WANGER ASSET MANAGEMENT LLC, BlackRock Fund Advisors, JENNISON ASSOCIATES LLC, State Street Corp, BlackRock Institutional Trust Company, N.A., and Bank of New York Mellon Corp. This page lists 143 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.